Theragenics (FRA:THX) Days Sales Outstanding : 46.61 (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Theragenics Days Sales Outstanding?

Theragenics's average Accounts Receivable for the three months ended in Jun. 2013 was €7.86 Mil. Theragenics's Revenue for the three months ended in Jun. 2013 was €15.39 Mil. Hence, Theragenics's Days Sales Outstanding for the three months ended in Jun. 2013 was 46.61.

The historical rank and industry rank for Theragenics's Days Sales Outstanding or its related term are showing as below:

FRA:THX's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 64.88
* Ranked among companies with meaningful Days Sales Outstanding only.

Theragenics's Days Sales Outstanding declined from Jun. 2012 (47.50) to Jun. 2013 (46.61).

Theragenics Days Sales Outstanding Historical Data

The historical data trend for Theragenics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragenics Days Sales Outstanding Chart

Theragenics Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Days Sales Outstanding

Get a 7-Day Free Trial

42.94

42.41

39.38

46.09

44.85

Theragenics Quarterly Data
	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13
Days Sales Outstanding	Get a 7-Day Free Trial															47.50	51.67	46.59	43.84	46.61

Competitive Comparison of Theragenics's Days Sales Outstanding

For the Medical Devices subindustry, Theragenics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theragenics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theragenics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Theragenics's Days Sales Outstanding falls into.

Theragenics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Theragenics's Days Sales Outstanding for the fiscal year that ended in Dec. 2012 is calculated as

	Days Sales Outstanding (A: Dec. 2012 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2011 )	+	Accounts Receivable (A: Dec. 2012 ))	/	count )	/	Revenue (A: Dec. 2012 )	*	Days in Period
=	( (8.645	+	6.817)	/	2 )	/	62.91	*	365
=	7.731					/	62.91	*	365
=	44.85

Theragenics's Days Sales Outstanding for the quarter that ended in Jun. 2013 is calculated as:

	Days Sales Outstanding (Q: Jun. 2013 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2013 )	+	Accounts Receivable (A: Jun. 2013 ))	/	count )	/	Revenue (A: Jun. 2013 )	*	Days in Period
=	( (7.924	+	7.795)	/	2 )	/	15.387	*	365 / 4
=	7.8595					/	15.387	*	365 / 4
=	46.61

Theragenics (FRA:THX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Theragenics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Theragenics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragenics (FRA:THX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theragenics Corporation (FRA:THX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.theragenics.com

Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.

Theragenics (FRA:THX) Headlines

No Headlines